26 January 2026
\n \n \n \nNew research carried out by Dr Loren Kell at NDORMS, has demonstrated for the first time that rapamycin can reduce DNA damage in immune cells, a hallmark of ageing.
\n \n\n \n \n23 January 2026
\n \n \n \nOxford Trauma and Emergency Care at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), along with the Critical Care Research Team at Nuffield Department of Clinical Neurosciences (NDCN) have formally become a new Institute within the University of Oxford: the Kadoorie Institute for Trauma, Emergency and Critical Care.
\n \n\n \n \n22 January 2026
\n \n \n \n\n \n \n22 January 2026
\n \n \n \nThe use of medications for Attention-Deficit Hyperactivity Disorder (ADHD) has increased substantially across Europe over the past decade, with the steepest rises seen among adults - particularly women - according to a large population-based study published in The Lancet Regional Health \u2013 Europe.
\n \n\n \n \n21 January 2026
\n \n \n \nResearchers at NDORMS have found that surgery for a displaced medial epicondyle fracture of the elbow in children offers no clinical benefit compared to non-surgical care. The findings could have significant implications for treatment and offer huge cost savings to the NHS.
\n \n\n \n \n14 January 2026
\n \n \n \nResearch led by Dr Mariana Borsa at the Kennedy Institute has found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T cells generate diverse progenies upon cell division. The findings, published in Nature Cell Biology, could help boost vaccine response in older adults.
\n \n\n \n \n18 December 2025
\n \n \n \nTogether with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.
\n \n\n \n \n10 December 2025
\n \n \n \nThe prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.
\n \n\n \n \n9 December 2025
\n \n \n \nA collaborative study, which includes contributions from NDORMS researchers Aaron Crowther and supervisor Dario Carugo, explores new ways to model bladder biology and infection, allowing evaluation of antimicrobial therapies under physiologically relevant conditions.
\n \n\n \n \n9 December 2025
\n \n \n \nResearchers from the University of Oxford have benchmarked artificial intelligence (AI) tools capable of automatically removing personal information from patient electronic health records (EHRs) in a key step towards enabling large-scale, confidential medical research.
\n \n\n \n \n5 December 2025
\n \n \n \nTwo research groups at NDORMS have joined the newly launched PROBE initiative, contributing their expertise to a major European collaboration focused on improving the understanding, diagnosis and treatment of osteoarthritis.
\n \n\n \n \n3 December 2025
\n \n \n \nSara Khalid\u2019s Planetary Health Informatics group has been awarded funding from the Gates Foundation\u2019s Grand Challenges initiative to investigate the epidemiology and impact of heavy menstrual bleeding in low-resource settings.
\n \n\n \n \n2 December 2025
\n \n \n \nA new national study has found that single-event multi-level surgery (SEMLS) helps straighten the legs and improves walking ability in children with cerebral palsy.
\n \n\n \n \n1 December 2025
\n \n \n \nNDORMS DPhil student Maria Kyriazi has won the prestigious Young Star Award at the fourth Greek International Women Awards in Athens.
\n \n\n \n \n21 November 2025
\n \n \n \nHigher BMI is not linked to increased risk of death or other complications following shoulder replacement surgery, according to a new study by Epaminondas Markos Valsamis from NDORMS, University of Oxford.
\n \n\n \n \n19 November 2025
\n \n \n \nNew research from a randomised clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.
\n \n\n \n \n18 November 2025
\n \n \n \nGSK invests \u00a310 million over five years to establish the Experimental Medicine Collaboration with the University of Oxford.
\n \n\n \n \n14 November 2025
\n \n \n \nResearchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.
\n \n\n \n \n12 November 2025
\n \n \n \nProfessor Tonia Vincent is part of an interdisciplinary team from Oxford University leading a major new initiative which aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.
\n \n\n \n \n5 November 2025
\n \n \n \nResearchers from the Kennedy Institute are part of a UK-wide consortium that has been awarded a \u00a3644K BBSRC Network Grant to establish the Microbiome Innovation Network (Microbiome-Net).
\n \n\n \n \n